ID24910A - Karboksilat nukleosid hemisulfat dan penggunaan dalam perlakuan infeksi viral - Google Patents

Karboksilat nukleosid hemisulfat dan penggunaan dalam perlakuan infeksi viral

Info

Publication number
ID24910A
ID24910A IDW991393A ID991393A ID24910A ID 24910 A ID24910 A ID 24910A ID W991393 A IDW991393 A ID W991393A ID 991393 A ID991393 A ID 991393A ID 24910 A ID24910 A ID 24910A
Authority
ID
Indonesia
Prior art keywords
carboxicate
hemisulfate
nucleoside
viral infection
infection treatment
Prior art date
Application number
IDW991393A
Other languages
English (en)
Inventor
Alastair Couper Brodie
Martin Francis Jones
John Frederick Seager
Christopher John Wallis
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10812407&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ID24910(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ID24910A publication Critical patent/ID24910A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
IDW991393A 1997-05-17 1998-05-14 Karboksilat nukleosid hemisulfat dan penggunaan dalam perlakuan infeksi viral ID24910A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9709945.1A GB9709945D0 (en) 1997-05-17 1997-05-17 A novel salt

Publications (1)

Publication Number Publication Date
ID24910A true ID24910A (id) 2000-08-31

Family

ID=10812407

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991393A ID24910A (id) 1997-05-17 1998-05-14 Karboksilat nukleosid hemisulfat dan penggunaan dalam perlakuan infeksi viral

Country Status (51)

Country Link
US (1) US6294540B1 (id)
EP (1) EP0983271B1 (id)
JP (2) JP3150711B2 (id)
KR (1) KR100521292B1 (id)
CN (2) CN100408580C (id)
AP (1) AP2009A (id)
AR (2) AR015668A1 (id)
AT (1) ATE259811T1 (id)
AU (1) AU739953B2 (id)
BG (1) BG64390B1 (id)
BR (1) BRPI9809126B8 (id)
CA (1) CA2289753C (id)
CO (1) CO4940435A1 (id)
DE (1) DE69821758T2 (id)
DK (1) DK0983271T3 (id)
DZ (1) DZ2493A1 (id)
EA (1) EA001809B1 (id)
EE (1) EE03924B1 (id)
EG (1) EG23836A (id)
ES (1) ES2214712T3 (id)
GB (3) GB9709945D0 (id)
GE (1) GEP20022680B (id)
HK (1) HK1024236A1 (id)
HN (1) HN1998000071A (id)
HR (1) HRP980265B1 (id)
HU (1) HU226563B1 (id)
ID (1) ID24910A (id)
IL (2) IL132793A0 (id)
IS (1) IS2207B (id)
JO (1) JO2032B1 (id)
MA (1) MA26498A1 (id)
MY (1) MY120151A (id)
NO (1) NO324731B1 (id)
NZ (2) NZ500865A (id)
OA (1) OA11304A (id)
PA (1) PA8451301A1 (id)
PE (1) PE78799A1 (id)
PL (1) PL189527B1 (id)
PT (1) PT983271E (id)
RS (1) RS49655B (id)
SA (1) SA98190179B1 (id)
SI (1) SI0983271T1 (id)
SK (1) SK285159B6 (id)
SV (1) SV1998000057A (id)
TN (1) TNSN98065A1 (id)
TR (1) TR199902810T2 (id)
TW (1) TW480259B (id)
UA (1) UA56231C2 (id)
UY (1) UY25004A1 (id)
WO (1) WO1998052949A1 (id)
ZA (2) ZA984085B (id)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9802472D0 (en) * 1998-02-06 1998-04-01 Glaxo Group Ltd Pharmaceutical compositions
HU226998B1 (en) * 2000-11-23 2010-04-28 Richter Gedeon Nyrt Desloratadine hemisulphate, process for the preparation thereof and pharmaceutical compositions containing the same
GB0320738D0 (en) 2003-09-04 2003-10-08 Glaxo Group Ltd Novel process
EP1905772A1 (en) * 2006-09-28 2008-04-02 Esteve Quimica, S.A. Process for the preparation of abacavir
AU2007301934A1 (en) * 2006-09-28 2008-04-03 Esteve Quimica, S.A. Process for the preparation of abacavir
EP2085397A1 (en) 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
EP2218721A1 (en) * 2009-02-11 2010-08-18 LEK Pharmaceuticals d.d. Novel salts of sitagliptin
EP2305680A3 (en) 2009-09-30 2011-05-18 Aurobindo Pharma Limited Novel salts of (1S,4R)-cis-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-methanol
KR20170078868A (ko) 2010-01-27 2017-07-07 비이브 헬쓰케어 컴퍼니 항바이러스 치료
ES2729824T3 (es) 2011-04-08 2019-11-06 Laurus Labs Ltd Formas sólidas de compuestos antirretrovirales, procedimiento para la preparación y composición farmacéutica de los mismos
US9457028B2 (en) 2013-02-27 2016-10-04 Kyoto University Pharmaceutical composition for use in prevention or treatment of cancer
CN104788451A (zh) * 2014-01-21 2015-07-22 浙江九洲药业股份有限公司 一种阿巴卡韦的制备方法
CN105315280A (zh) * 2014-06-06 2016-02-10 上海迪赛诺化学制药有限公司 一种阿巴卡韦结晶体及其制备方法
US10874687B1 (en) 2020-02-27 2020-12-29 Atea Pharmaceuticals, Inc. Highly active compounds against COVID-19

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
GB9417249D0 (en) 1994-08-26 1994-10-19 Wellcome Found A novel salt
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
ATE230267T1 (de) * 1996-06-25 2003-01-15 Glaxo Group Ltd Zusammensetzungen enthaltend vx478, zidovudine und 159u89 für die verwendung in der behandlung von hiv

Also Published As

Publication number Publication date
NO324731B1 (no) 2007-12-03
IL132793A0 (en) 2001-03-19
EA001809B1 (ru) 2001-08-27
TNSN98065A1 (fr) 2005-03-15
GB0010222D0 (en) 2000-06-14
GB9926839D0 (en) 2000-01-12
GB2348202A (en) 2000-09-27
EE9900537A (et) 2000-06-15
NZ510622A (en) 2002-04-26
IL132793A (en) 2006-10-31
IS5246A (is) 1999-11-11
HUP0002754A2 (hu) 2001-06-28
NZ500865A (en) 2001-04-27
YU59599A (id) 2002-08-12
KR20010012623A (ko) 2001-02-26
SA98190179B1 (ar) 2006-08-15
TW480259B (en) 2002-03-21
DZ2493A1 (fr) 2004-06-20
PE78799A1 (es) 1999-08-31
EA199900944A1 (ru) 2000-06-26
UA56231C2 (uk) 2003-05-15
SK156199A3 (en) 2000-07-11
PA8451301A1 (es) 2000-05-24
KR100521292B1 (ko) 2005-10-17
ZA984083B (en) 1999-11-15
AR015668A1 (es) 2001-05-16
SK285159B6 (sk) 2006-07-07
AP9901688A0 (en) 1999-12-31
MA26498A1 (fr) 2004-12-20
HRP980265A2 (en) 1999-02-28
AU7765598A (en) 1998-12-11
DE69821758D1 (de) 2004-03-25
CA2289753A1 (en) 1998-11-26
BR9809126A (pt) 2000-08-01
AR059120A2 (es) 2008-03-12
AU739953B2 (en) 2001-10-25
GEP20022680B (en) 2002-04-25
WO1998052949A1 (en) 1998-11-26
ES2214712T3 (es) 2004-09-16
GB2340491A (en) 2000-02-23
HK1024236A1 (en) 2000-10-05
TR199902810T2 (xx) 2000-02-21
JP3150711B2 (ja) 2001-03-26
ZA984085B (en) 2000-01-26
CN1515572A (zh) 2004-07-28
DK0983271T3 (da) 2004-05-10
SV1998000057A (es) 1999-03-02
BG64390B1 (bg) 2004-12-30
BRPI9809126B8 (pt) 2021-07-06
AP2009A (en) 2009-06-26
EE03924B1 (et) 2002-12-16
HU226563B1 (en) 2009-04-28
BG103959A (en) 2000-12-29
NO995622D0 (no) 1999-11-16
GB2340491B (en) 2000-10-18
NO995622L (no) 2000-01-14
SI0983271T1 (en) 2004-06-30
PT983271E (pt) 2004-07-30
RS49655B (sr) 2007-09-21
CN100408580C (zh) 2008-08-06
JP2000514096A (ja) 2000-10-24
HUP0002754A3 (en) 2003-01-28
IS2207B (is) 2007-02-15
MY120151A (en) 2005-09-30
ATE259811T1 (de) 2004-03-15
JP2000327679A (ja) 2000-11-28
PL189527B1 (pl) 2005-08-31
PL336888A1 (en) 2000-07-17
HN1998000071A (es) 1999-03-19
JO2032B1 (en) 1999-05-15
CA2289753C (en) 2007-01-23
CO4940435A1 (es) 2000-07-24
US6294540B1 (en) 2001-09-25
OA11304A (en) 2003-10-22
EG23836A (en) 2007-10-02
HRP980265B1 (en) 2004-10-31
EP0983271B1 (en) 2004-02-18
GB2348202B (en) 2001-08-08
DE69821758T2 (de) 2005-01-13
BRPI9809126B1 (pt) 2018-02-06
UY25004A1 (es) 2000-10-31
CN1150194C (zh) 2004-05-19
EP0983271A1 (en) 2000-03-08
GB9709945D0 (en) 1997-07-09
CN1263529A (zh) 2000-08-16

Similar Documents

Publication Publication Date Title
PT712862E (pt) Acilacao selectiva de grupos epsilon-amino em ensulina
NO992373L (no) Forlenget anestesi i ledd og kroppshulrom
DK1087778T3 (da) Anvendelse af PEG-IFN-alfa og Ribavirin til behandling af kronisk hepatitis C
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
DE69811135D1 (de) Keramischer Wabenkörper
ID24910A (id) Karboksilat nukleosid hemisulfat dan penggunaan dalam perlakuan infeksi viral
ID20600A (id) Sel-sel yang dimodifikasi secara genetik dan penggunaannya dalam profilaksis atau terapi penyakit
AU5732198A (en) Use of the ah receptor and ah receptor ligands to treat or prevent the cytopathicity of viral infection
DE69707347D1 (de) Keramischer Wabenkörper
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
NO984836D0 (no) Substituerte benzylaminer og deres anvendelse for behandling av depresjon
BR9509641A (pt) Sequências de dna e seu uso
DE69914158D1 (de) Adenosin enthaltendes Haartonikum
DE59909860D1 (de) Anwendung von 5'-modifizierten nukleotiden in der molekularbiologie und medizin
DE69918447D1 (de) Antivirale kombinationen von lamivudin und adefovir
DK0876146T3 (da) Nucleoside analoger i kombinationsterapi af herpes simplex infektioner
ZA983740B (en) Novel amidine derivatives and their use in therapy
EE200000018A (et) 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine
DE59812220D1 (de) Halte- und trageband
FR2718749B1 (fr) Vecteurs viraux et utilisation en thérapie génique.
ID16730A (id) Dihidro pirimidina dan penggunaannya
BR7400443U (pt) Disposição introduzida em maleta descartável
ID20518A (id) Turunan-turunan oksazolon dan penggunaannya
BA98291A (bs) Epoksi-azetidinoni priprava i upotreba